When “Efficacy” Isn’t Just About Medicine: The Delhi High Court’s Syngenta Ruling
Every patent professional who has prosecuted a patent application for a pharmaceutical invention in India knows the routine: the examiner issues a Section 3(d) objection, cites the landmark Novartis judgment, and demands comparative data showing enhanced therapeutic efficacy. But what happens when the invention isn't a pharmaceutical drug at all; but an agrochemical or